γδ T cells play a protective role in Chikungunya virus-induced disease

Journal of Virology

Volumn 90, Issue 1, 2016, Pages 433-443

  Long, Kristin M ^a   Ferris, Martin T ^a   Whitmore, Alan C ^a   Montgomery, Stephanie A ^a,b   Thurlow, Lance R ^a   McGee, Charles E ^a,d   Rodriguez, Carlos A ^c   Lim, Jean K ^c   Heise, Mark T ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FOOT EDEMA; GAMMA DELTA T LYMPHOCYTE; INFLAMMATION; LYMPH NODE; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION; WEIGHT GAIN; WILD TYPE; ANIMAL; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; CYTOCHEMISTRY; DISEASE MODEL; GENETICS; HINDLIMB; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; BODY WEIGHT; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; DISEASE MODELS, ANIMAL; HINDLIMB; HISTOCYTOCHEMISTRY; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES;

EID: 84953861239     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02159-15     Document Type: Article

References (107)

1. Powers AM, Logue CH. 2007. Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 88:2363-2377. http://dx.doi.org/10.1099/vir.0.82858-0.
2. Lumsden WH. 1955. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans R Soc Trop Med Hyg 49:33-57.
3. Robinson MC. 1955. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg 49:28-32. http://dx.doi.org/10.1016/0035-9203(55)90080-8.
4. Suhrbier A, La Linn M. 2004. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr Opin Rheumatol 16:374-379. http://dx.doi.org/10.1097/01.bor.0000130537.76808.26.
5. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Brehin AC, Cubito N, Despres P, Kunst F, Rey FA, Zeller H, Brisse S. 2006. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 3:e263. http://dx.doi.org/10.1371/journal.pmed.0030263.
6. Simon F, Tolou H, Jeandel P. 2006. The unexpected Chikungunya outbreak. Rev Med Interne 27:437-441. (In French.) http://dx.doi.org/10.1016/j.revmed.2006.03.028.
7. Sergon K, Njuguna C, Kalani R, Ofula V, Onyango C, Konongoi LS, Bedno S, Burke H, Dumilla AM, Konde J, Njenga MK, Sang R, Breiman RF. 2008. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg 78:333-337.
8. Sergon K, Yahaya AA, Brown J, Bedja SA, Mlindasse M, Agata N, Allaranger Y, Ball MD, Powers AM, Ofula V, Onyango C, Konongoi LS, Sang R, Njenga MK, Breiman RF. 2007. Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg 76:1189-1193.
9. Laras K, Sukri NC, Larasati RP, Bangs MJ, Kosim R, Djauzi Wandra T, Master J, Kosasih H, Hartati S, Beckett C, Sedyaningsih ER, Beecham HJ, III, Corwin AL. 2005. Tracking the re-emergence of epidemic Chikungunya virus in Indonesia. Trans R Soc Trop Med Hyg 99:128-141. http://dx.doi.org/10.1016/j.trstmh.2004.03.013.
10. Hochedez P, Jaureguiberry S, Debruyne M, Bossi P, Hausfater P, Brucker G, Bricaire F, Caumes E. 2006. Chikungunya infection in travelers. Emerg Infect Dis 12:1565-1567. http://dx.doi.org/10.3201/eid1210.060495.
11. Simon F, Savini H, Parola P. 2008. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med Clin North Am 92:1323-1343. http://dx.doi.org/10.1016/j.mcna.2008.07.008.
12. Parola P, de Lamballerie X, Jourdan J, Rovery C, Vaillant V, Minodier P, Brouqui P, Flahault A, Raoult D, Charrel RN. 2006. Novel Chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 12:1493-1499. http://dx.doi.org/10.3201/eid1210.060610.
13. Pfeffer M, Loscher T. 2006. Cases of chikungunya imported into Europe. Euro Surveill 11(3):E060316.2.
14. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. 2007. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7:319-327. http://dx.doi.org/10.1016/S1473-3099(07)70107-X.
15. Bottieau E, Van Esbroeck M, Cnops L, Clerinx J, Van Gompel A. 2009. Chikungunya infection confirmed in a Belgian traveller returning from Phuket (Thailand). Euro Surveill 14(25):pii=19248. http://www.eurosurveillance.org/ViewArticle.aspx?Articleid=19247.
16. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A, CHIKV Study Group. 2007. Infection with Chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370:1840-1846. http://dx.doi.org/10.1016/S0140-6736(07)61779-6.
17. Beltrame A, Angheben A, BisoffiZ, Monteiro G, Marocco S, Calleri G, Lipani F, Gobbi F, Canta F, Castelli F, Gulletta M, Bigoni S, Del Punta V, Iacovazzi T, Romi R, Nicoletti L, Ciufolini MG, Rorato G, Negri C, Viale P. 2007. Imported Chikungunya infection, Italy. Emerg Infect Dis 13:1264-1266. http://dx.doi.org/10.3201/eid1308.070161.
18. Angelini P, Macini P, Finarelli AC, Pol C, Venturelli C, Bellini R, Dottori M. 2008. Chikungunya epidemic outbreak in Emilia-Romagna (Italy) during summer 2007. Parassitologia 50:97-98.
19. Angelini R, Finarelli AC, Angelini P, Po C, Petropulacos K, Macini P, Fiorentini C, Fortuna C, Venturi G, Romi R, Majori G, Nicoletti L, Rezza G, Cassone A. 2007. An outbreak of Chikungunya fever in the province of Ravenna, Italy. Euro Surveill 12(36):pii=3260. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3260.
20. Hussain R, Alomar I, Memish ZA. 2013. Chikungunya virus: emergence of an arthritic arbovirus in Jeddah, Saudi Arabia. East Mediterr Health J 19:506-508.
21. Cassadou S, Boucau S, Petit-Sinturel M, Huc P, Leparc-Goffart I, Ledrans M. 2014. Emergence of Chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill 19(13): pii=20752. http://dx.doi.org/10.2087/1560-7917.ES2014.19.13.20752.
22. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X. 2014. Chikungunya in the Americas. Lancet 383:514. http://dx.doi.org/10.1016/S0140-6736(14)60185-9.
23. Van Bortel W, Dorleans F, Rosine J, Blateau A, Rousset D, Matheus S, Leparc-Goffart I, Flusin O, Prat C, Cesaire R, Najioullah F, Ardillon V, Balleydier E, Carvalho L, Lemaitre A, Noel H, Servas V, Six C, Zurbaran M, Leon L, Guinard A, van den Kerkhof J, Henry M, Fanoy E, Braks M, Reimerink J, Swaan C, Georges R, Brooks L, Freedman J, Sudre B, Zeller H. 2014. Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill 19(13):pii=20759. http://dx.doi.org/10.2807/1560-7917.ES2014.19.13.20759.
24. Centers for Disease Control and Prevention. 2014. Chikungunya virus. CDC, Atlanta, GA.
25. Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, Quenel P, Germonneau P, Quatresous I. 2009. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Reunion. Epidemiol Infect 137:534-541. http://dx.doi.org/10.1017/S0950268808001167.
26. Josseran L, Paquet C, Zehgnoun A, Caillere N, Le Tertre A, Solet JL, Ledrans M. 2006. Chikungunya disease outbreak, Reunion Island. Emerg Infect Dis 12:1994-1995. http://dx.doi.org/10.3201/eid1212.060710.
27. Chua HH, Abdul Rashid K, Law WC, Hamizah A, Chem YK, Khairul AH, Chua KB. 2010. A fatal case of Chikungunya virus infection with liver involvement. Med J Malaysia 65:83-84.
28. Rampal Sharda M, Meena H. 2007. Neurological complications in Chikungunya fever. J Assoc Physicians India 55:765-769.
29. Rampal Sharda M, Meena H. 2007. Hypokalemic paralysis following Chikungunya fever. J Assoc Physicians India 55:598.
30. Wielanek AC, Monredon JD, Amrani ME, Roger JC, Serveaux JP. 2007. Guillain-Barre syndrome complicating a Chikungunya virus infection. Neurology 69:2105-2107. http://dx.doi.org/10.1212/01.wnl.0000277267.07220.88.
31. Vazeille M, Jeannin C, Martin E, Schaffner F, Failloux AB. 2008. Chikungunya: a risk for Mediterranean countries? Acta Trop 105:200-202. http://dx.doi.org/10.1016/j.actatropica.2007.09.009.
32. Vazeille M, Moutailler S, Coudrier D, Rousseaux C, Khun H, Huerre M, Thiria J, Dehecq JS, Fontenille D, Schuffenecker I, Despres P, Failloux AB. 2007. Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One 2:e1168. http://dx.doi.org/10.1371/journal.pone.0001168.
33. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. 2007. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 3:e201. http://dx.doi.org/10.1371/journal.ppat.0030201.
34. Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. 1999. Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am J Trop Med Hyg 60:281-286.
35. Delatte H, Dehecq JS, Thiria J, Domerg C, Paupy C, Fontenille D. 2008. Geographic distribution and developmental sites of Aedes albopictus (Diptera: Culicidae) during a Chikungunya epidemic event. Vector Borne Zoonotic Dis 8:25-34. http://dx.doi.org/10.1089/vbz.2007.0649.
36. Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Ali Mohamed A, de Lamballerie X, Charrel R, Tolou H. 2007. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) 86:123-137. http://dx.doi.org/10.1097/MD/0b013e31806010a5.
37. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V. 2009. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 3:e389. http://dx.doi.org/10.1371/journal.pntd.0000389.
38. Mourya DT, Mishra AC. 2006. Chikungunya fever. Lancet 368:186-187. http://dx.doi.org/10.1016/S0140-6736(06)69017-X.
39. Yazdani R, Kaushik VV. 2007. Chikungunya fever. Rheumatology (Oxford) 46:1214-1215. http://dx.doi.org/10.1093/rheumatology/kem059.
40. Fourie ED, Morrison JG. 1979. Rheumatoid arthritic syndrome after Chikungunya fever. S Afr Med J 56:130-132.
41. Kennedy AC, Fleming J, Solomon L. 1980. Chikungunya viral arthropathy: a clinical description. J Rheumatol 7:231-236.
42. Brighton SW, Simson IW. 1984. A destructive arthropathy following Chikungunya virus arthritis: a possible association. Clin Rheumatol 3:253-258. http://dx.doi.org/10.1007/BF02030766.
43. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, Sudeep AB, Muruganandam N, Chaitanya IK, Guruprasad DR. 2010. Clinical progression of Chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392-399. http://dx.doi.org/10.1016/j.trstmh.2010.01.011.
44. Soumahoro MK, Gerardin P, Boelle PY, Perrau J, Fianu A, Pouchot J, Malvy D, Flahault A, Favier F, Hanslik T. 2009. Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One 4:e7800. http://dx.doi.org/10.1371/journal.pone.0007800.
45. Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K. 2013. Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J 89:440-447. http://dx.doi.org/10.1136/postgradmedj-2012-131477.
46. Poo YS, Nakaya H, Gardner J, Larcher T, Schroder WA, Le TT, Major LD, Suhrbier A. 2014. CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated Chikungunya virus arthritis. J Virol 88: 6862-6872. http://dx.doi.org/10.1128/JVI.03364-13.
47. Hoarau JJ, Gay F, Pelle O, Samri A, Jaffar-Bandjee MC, Gasque P, Autran B. 2013. Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island. PLoS One 8:e84695. http://dx.doi.org/10.1371/journal.pone.0084695.
48. Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, Morrison TE. 2013. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J Virol 87:13878-13888. http://dx.doi.org/10.1128/JVI.02666-13.
49. Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P. 2012. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 6:e1446. http://dx.doi.org/10.1371/journal.pntd.0001446.
50. Stoermer KA, Burrack A, Oko L, Montgomery SA, Borst LB, Gill RG, Morrison TE. 2012. Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus. J Immunol 189:4047-4059. http://dx.doi.org/10.4049/jimmunol.1201240.
51. Kam YW, Simarmata D, Chow A, Her Z, Teng TS, Ong EK, Renia L, Leo YS, Ng LF. 2012. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with Chikungunya virus clearance and longterm clinical protection. J Infect Dis 205:1147-1154. http://dx.doi.org/10.1093/infdis/jis033.
52. Jupille HJ, Oko L, Stoermer KA, Heise MT, Mahalingam S, Gunn BM, Morrison TE. 2011. Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology 410:216-227. http://dx.doi.org/10.1016/j.virol.2010.11.012.
53. Morrison TE, Simmons JD, Heise MT. 2008. Complement receptor 3 promotes severe ross river virus-induced disease. J Virol 82:11263-11272. http://dx.doi.org/10.1128/JVI.01352-08.
54. Morrison TE, Fraser RJ, Smith PN, Mahalingam S, Heise MT. 2007. Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J Virol 81:5132-5143. http://dx.doi.org/10.1128/JVI.02799-06.
55. Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT. 2006. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol 80:737-749. http://dx.doi.org/10.1128/JVI.80.2.737-749.2006.
56. Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, Herrero LJ, Ramirez R, Smith PN, Mahalingam S, Heise MT. 2012. Mannose binding lectin is required for alphavirus-induced arthritis/myositis. PLoS Pathog 8:e1002586. http://dx.doi.org/10.1371/journal.ppat.1002586.
57. Lidbury BA, Simeonovic C, Maxwell GE, Marshall ID, Hapel AJ. 2000. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis 181:27-34. http://dx.doi.org/10.1086/315164.
58. Van Den Bossche D, Cnops L, Meersman K, Domingo C, Van Gompel A, Van Esbroeck M. 2015. Chikungunya virus and West Nile virus infections imported into Belgium, 2007-2012. Epidemiol Infect 143: 2227-2236. http://dx.doi.org/10.1017/S0950268814000685.
59. Long KM, Whitmore AC, Ferris MT, Sempowski GD, McGee C, Trollinger B, Gunn B, Heise MT. 2013. Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice. J Virol 87:5697-5706. http://dx.doi.org/10.1128/JVI.01611-12.
60. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM. 2011. The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis 204:115-123. http://dx.doi.org/10.1093/infdis/jiq006.
61. Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Despres P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. 2008. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 4:e29. http://dx.doi.org/10.1371/journal.ppat.0040029.
62. Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML. 2010. Type I IFN controls Chikungunya virus via its action on nonhematopoietic cells. J Exp Med 207:429-442. http://dx.doi.org/10.1084/jem.20090851.
63. Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ. 2011. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog 7:e1002322. http://dx.doi.org/10.1371/journal.ppat.1002322.
64. Gardner CL, Burke CW, Higgs ST, Klimstra WB, Ryman KD. 2012. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type Chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. Virology 425:103-112. http://dx.doi.org/10.1016/j.virol.2011.12.020.
65. Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH, Lulla A, Yeo NK, Koh EG, Chow A, Leo YS, Merits A, Chin KC, Ng LF. 2012. Viperin restricts Chikungunya virus replication and pathology. J Clin Invest 122: 4447-4460. http://dx.doi.org/10.1172/JCI63120.
66. Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, Schroder WA, Higgs S, Suhrbier A. 2010. Chikungunya virus arthritis in adult wild-type mice. J Virol 84:8021-8032. http://dx.doi.org/10.1128/JVI.02603-09.
67. Lum FM, Teo TH, Lee WW, Kam YW, Renia L, Ng LF. 2013. An essential role of antibodies in the control of Chikungunya virus infection. J Immunol 190:6295-6302. http://dx.doi.org/10.4049/jimmunol.1300304.
68. Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT. 2011. A mouse model of Chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol 178:32-40. http://dx.doi.org/10.1016/j.ajpath.2010.11.018.
69. + T cells during Chikungunya virus infection in mice. J Immunol 190:259-269. http://dx.doi.org/10.4049/jimmunol.1202177.
70. Lee WW, Teo TH, Her Z, Lum FM, Kam YW, Haase D, Renia L, Rotzschke O, Ng LF. 2015. Expanding regulatory T cells alleviates Chikungunya virus-induced pathology in mice. J Virol 89:7893-7904. http://dx.doi.org/10.1128/JVI.00998-15.
71. Hayday AC. 2000. γδ cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 18:975-1026. http://dx.doi.org/10.1146/annurev.immunol.18.1.975.
72. Born W, Cady C, Jones-Carson J, Mukasa A, Lahn M, O'Brien R. 1999. Immunoregulatory functions of gamma delta T cells. Adv Immunol 71: 77-144.
73. Carding SR, Egan PJ. 2002. γδ T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2:336-345. http://dx.doi.org/10.1038/nri797.
74. Egan PJ, Carding SR. 2000. Downmodulation of the inflammatory response to bacterial infection by γδ T cells cytotoxic for activated macrophages. J Exp Med 191:2145-2158. http://dx.doi.org/10.1084/jem.191.12.2145.
75. Fu YX, Roark CE, Kelly K, Drevets D, Campbell P, O'Brien R, Born W. 1994. Immune protection and control of inflammatory tissue necrosis by gamma delta T cells. J Immunol 153:3101-3115.
76. D'Souza CD, Cooper AM, Frank AA, Mazzaccaro RJ, Bloom BR, Orme IM. 1997. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 158:1217-1221.
77. Hisaeda H, Sakai T, Nagasawa H, Ishikawa H, Yasutomo K, Maekawa Y, Himeno K. 1996. Contribution of extrathymic gamma delta T cells to the expression of heat-shock protein and to protective immunity in mice infected with Toxoplasma gondii. Immunology 88:551-557. http://dx.doi.org/10.1046/j.1365-2567.1996.d01-694.x.
78. Dalton JE, Pearson J, Scott P, Carding SR. 2003. The interaction of gamma delta T cells with activated macrophages is a property of the V gamma 1 subset. J Immunol 171:6488-6494. http://dx.doi.org/10.4049/jimmunol.171.12.6488.
79. Tramonti D, Rhodes K, Martin N, Dalton JE, Andrew E, Carding SR. 2008. γδ T cell-mediated regulation of chemokine producing macrophages during Listeria monocytogenes infection-induced inflammation. J Pathol 216:262-270. http://dx.doi.org/10.1002/path.2412.
80. Fang H, Welte T, Zheng X, Chang GJ, Holbrook MR, Soong L, Wang T. 2010. γδ T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol Med Microbiol 59:71-80. http://dx.doi.org/10.1111/j.1574-695X.2010.00663.x.
81. Safavi F, Feliberti JP, Raine CS, Mokhtarian F. 2011. Role of γδ T cells in antibody production and recovery from SFV demyelinating disease. J Neuroimmunol 235:18-26. http://dx.doi.org/10.1016/j.jneuroim.2011.02.013.
82. Wang T, Scully E, Yin Z, Kim JH, Wang S, Yan J, Mamula M, Anderson JF, Craft J, Fikrig E. 2003. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J Immunol 171:2524-2531. http://dx.doi.org/10.4049/jimmunol.171.5.2524.
83. Paessler S, Ni H, Petrakova O, Fayzulin RZ, Yun N, Anishchenko M, Weaver SC, Frolov I. 2006. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. J Virol 80:2784-2796. http://dx.doi.org/10.1128/JVI.80.6.2784-2796.2006.
84. Paessler S, Yun NE, Judy BM, Dziuba N, Zacks MA, Grund AH, Frolov I, Campbell GA, Weaver SC, Estes DM. 2007. Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology 367:307-323. http://dx.doi.org/10.1016/j.virol.2007.05.041.
85. Nakaya HI, Gardner J, Poo YS, Major L, Pulendran B, Suhrbier A. 2012. Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum 64:3553-3563. http://dx.doi.org/10.1002/art.34631.
86. Crow JP, Beckman JS. 1995. Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv Pharmacol 34:17-43. http://dx.doi.org/10.1016/S1054-3589(08)61079-0.
87. Crow JP, Beckman JS. 1995. The role of peroxynitrite in nitric oxidemediated toxicity. Curr Top Microbiol Immunol 196:57-73.
88. Kaur H, Halliwell B. 1994. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 350:9-12.
89. Nemirovskiy OV, Radabaugh MR, Aggarwal P, Funckes-Shippy CL, Mnich SJ, Meyer DM, Sunyer T, Rodney Mathews W, Misko TP. 2009. Plasma 3-nitrotyrosine is a biomarker in animal models of arthritis: pharmacological dissection of iNOS' role in disease. Nitric Oxide 20: 150-156. http://dx.doi.org/10.1016/j.niox.2008.12.005.
90. Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S. 2011. Protection from arthritis and myositis in a mouse model of acute Chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis 204: 1026-1030. http://dx.doi.org/10.1093/infdis/jir470.
91. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, Cavrini F, Pierro A, Rossini G, Cameron MJ, Bermejo-Martin JF, Paquette SG, Xu L, Danesh A, Farooqui A, Borghetto I, Kelvin DJ, Sambri V, Rubino S. 2011. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 5:e1279. http://dx.doi.org/10.1371/journal.pntd.0001279.
92. Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML. 2012. Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection. J Immunol 188:2967-2971. http://dx.doi.org/10.4049/jimmunol.1103185.
93. Kam YW, Ong EK, Renia L, Tong JC, Ng LF. 2009. Immuno-biology of Chikungunya and implications for disease intervention. Microbes Infect 11:1186-1196. http://dx.doi.org/10.1016/j.micinf.2009.09.003.
94. Clavarino G, Claudio N, Couderc T, Dalet A, Judith D, Camosseto V, Schmidt EK, Wenger T, Lecuit M, Gatti E, Pierre P. 2012. Induction of GADD34 is necessary for dsRNA-dependent interferon-beta production and participates in the control of Chikungunya virus infection. PLoS Pathog 8:e1002708. http://dx.doi.org/10.1371/journal.ppat.1002708.
95. Welte T, Lamb J, Anderson JF, Born WK, O'Brien RL, Wang T. 2008. Role of two distinct γδ T cell subsets during West Nile virus infection. FEMS Immunol Med Microbiol 53:275-283. http://dx.doi.org/10.1111/j.1574-695X.2008.00430.x.
96. Wang T. 2011. Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe? J Neuroimmunol 240-241:22-27. http://dx.doi.org/10.1016/j.neuroim.2011.10.004.
97. + T cells regulate host immune response to West Nile virus infection. FEMS Immunol Med Microbiol 63:183-192. http://dx.doi.org/10.1111/j.1574-695X.2011.00840.x.
98. Griffin DE, Levine B, Tyor WR, Irani DN. 1992. The immune response in viral encephalitis. Semin Immunol 4:111-119.
99. Chomarat P, Kjeldsen-Kragh J, Quayle AJ, Natvig JB, Miossec P. 1994. Different cytokine production profiles of gamma delta T cell clones: relation to inflammatory arthritis. Eur J Immunol 24:2087-2091. http://dx.doi.org/10.1002/eji.1830240923.
100. Huber S, Shi C, Budd RC. 2002. γδ T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol 76: 6487-6494. http://dx.doi.org/10.1128/JVI.76.13.6487-6494.2002.
101. Nishimura H, Yajima T, Kagimoto Y, Ohata M, Watase T, Kishihara K, Goshima F, Nishiyama Y, Yoshikai Y. 2004. Intraepithelial γδ T cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2. J Virol 78:4927-4930. http://dx.doi.org/10.1128/JVI.78.9.4927-4930.2004.
102. Ferrick DA, King DP, Jackson KA, Braun RK, Tam S, Hyde DM, Beaman BL. 2000. Intraepithelial gamma delta T lymphocytes: sentinel cells at mucosal barriers. Springer Semin Immunopathol 22:283-296. http://dx.doi.org/10.1007/s002810000047.
103. O'Brien RL, Roark CL, Born WK. 2009. IL-17-producing γδ T cells. Eur J Immunol 39:662-666. http://dx.doi.org/10.1002/eji.200839120.
104. Aoyagi M, Shimojo N, Sekine K, Nishimuta T, Kohno Y. 2003. Respiratory syncytial virus infection suppresses IFN-gamma production of γδ T cells. Clin Exp Immunol 131:312-317. http://dx.doi.org/10.1046/j.1365-2249.2003.02062.x.
105. Toka FN, Kenney MA, Golde WT. 2011. Rapid and transient activation of γδ T cells to IFN-γ production, NK cell-like killing, and antigen processing during acute virus infection. J Immunol 186:4853-4861. http://dx.doi.org/10.4049/jimmunol.1003599.
106. Tagawa T, Nishimura H, Yajima T, Hara H, Kishihara K, Matsuzaki G, Yoshino I, Maehara Y, Yoshikai Y. 2004. Vδ1+ γδ T cells producing CC chemokines may bridge a gap between neutrophils and macrophages in innate immunity during Escherichia coli infection in mice. J Immunol 173:5156-5164. http://dx.doi.org/10.4049/jimmunol.173.8.5156.
107. high gamma delta T cells in Lyme arthritis. J Exp Med 184:2109-2117. http://dx.doi.org/10.1084/jem.184.6.2109.